YUNGJIN PHARMACEUTICAL CO., LTD.

Patent Applications and Registrations

Patent applications and USPTO patent grants for YUNGJIN PHARMACEUTICAL CO., LTD..The latest application filed is for "a novel compound (ks-513) isolated from pseudolysimachion rotundum var. subintegrum, the composition comprising the same preventing or treating allergic disease, inflammatory disease, asthma or chronic obstructive pulmonary disease and the use thereof".

Company Profile

4.15.10

YUNGJIN PHARMACEUTICAL CO., LTD. - Seoul N/A KR
YUNGJIN PHARMACEUTICAL CO., LTD - Seoul N/A KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pharmaceutical composition for promoting bone tissue formation, containing Stauntonia hexaphylla leaf extract as active ingredient Grant 10,328,110 - Choi , et al.	2019-06-25
Method of treating chronic obstructive pulmonary disease (CPD) with verproside Grant 10,172,816 - Lee , et al. J	2019-01-08
Purified extract (ATC1) isolated from Pseudolysimachion rotundum var. subintegrum containing abundant amount of active ingredient, the preparation thereof, and the composition comprising the same as an active ingredient for preventing or treating inflammation, allergy and asthma Grant 10,046,019 - Lee , et al. August 14, 2	2018-08-14
Method of treating inflammation, allergy and asthma with a purified extract (ATC1) isolated from Pseudolysimachion rotundum var. subintegrum containing abundant amount of active ingredient Grant 9,999,646 - Lee , et al. June 19, 2	2018-06-19
A novel compound (KS-513) isolated from Pseudolysimachion rotundum var. subintegrum, the composition comprising the same preventing or treating allergic disease, inflammatory disease, asthma or chronic obstructive pulmonary disease and the use thereof App 20180105548 - LEE; Yongnam ; et al.	2018-04-19
Method Of Treating Chronic Obstructive Pulmonary Disease (CPD) With Verproside App 20170266142 - LEE; Yongnam ; et al.	2017-09-21
Compound isolated from Pseudolysimachion rotundum var. subintegrum, the composition comprising the same for treating allergic disease, inflammatory disease, asthma or chronic obstructive pulmonary disease and the use thereof App 20170217982 - LEE; Yongnam ; et al.	2017-08-03
Method of treating inflammation, allergy and asthma with a purified extract (ATC2) isolated from Pseudolysimachion rotundam var. subintegrum containing abundant amount of active ingredient Grant 9,675,658 - Lee , et al. June 13, 2	2017-06-13
Composition comprising a purified extract isolated from Pseudolysimachion rotundum var. subintegrum containing abundant amount of active ingredient or the compounds isolated therefrom, as an active ingredient for treating a chronic obstructive pulmonary disease and the use thereof Grant 9,655,871 - Lee , et al. May 23, 2	2017-05-23
Purified extract (ATC2) isolated from Pseudolysimachion rotundum var. subintegrum containing abundant amount of active ingredient, the preparation thereof, and the composition comprising the same as an active ingredient for preventing or treating inflammation, allergy and asthma Grant 9,592,263 - Lee , et al. March 14, 2	2017-03-14
Method Of Treating Inflammation, Allergy And Asthma With A Purified Extract (atc2) Isolated From Pseudolysimachion Rotundum Var. Subintegrum Containing Abundant Amount Of Active Ingredient App 20170049837 - LEE; Yongnam ; et al.	2017-02-23
Method Of Treating Inflammation, Allergy And Asthma With A Purified Extract (atc1) Isolated From Pseudolysimachion Rotundum Var. Subintegrum Containing Abundant Amount Of Active Ingredient App 20170049838 - LEE; Yongnam ; et al.	2017-02-23
Purified Extract isolated from Pseudolysimachion rotundum var. subintegrum containing abundant amount of active ingredient, the preparation thereof, and the composition comprising the same as an active ingredient for preventing or treating inflammation, allergy and asthma App 20170028010 - LEE; Yongnam ; et al.	2017-02-02
A Purified Extract isolated from Pseudolysimachion rotundum var. subintegrum containing abundant amount of active ingredient, the preparation thereof, and the composition comprising the same as an active ingredient for preventing or treating inflammation, allergy and asthma App 20160199430 - LEE; Yongnam ; et al.	2016-07-14
Pharmaceutical Composition For Promoting Bone Tissue Formation, Containing Stauntonia Hexaphylla Leaf Extract As Active Ingredient App 20160113979 - CHOI; Chul Yung ; et al.	2016-04-28
The Composition Comprising A Purified Extract Isolated From Pseudolysimachion Rotundum Var. Subintegrum Containing Abundant Amount Of Active Ingredient Or The Compounds Isolated Therefrom, As An Active Ingredient For Preventing Or Treating Chronic Obstructive Pulmonary Disease And The Use Thereof App 20160051612 - LEE; Yongnam ; et al.	2016-02-25
Heterocycle-fused thiazole derivatives Grant 6,043,373 - Yoo , et al. March 28, 2	2000-03-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.